<DOC>
	<DOCNO>NCT01693952</DOCNO>
	<brief_summary>Treatment cancer , particularly haematological malignancy , partly rely chemotherapy . Most therapeutic regimen display various toxicity , one common haematological toxicity , affect three lineage . While anaemia thrombopenia overcome haematological growth factor transfusion , one severe life-threatening toxicity sepsis develop neutropenia . Neutropenia , despite use granulocyte colony-stimulating factor ( G-CSF ) antibiotic , still major limitation chemotherapy responsible majority treatment-related morbidity mortality prolong hospitalisation . In neutropenic patient , sepsis frequent severe non-neutropenic patient . While occurence neutropenia sepsis often unpredictable thus difficult study prospective way , stem cell transplantation represent quite convenient model study question . Autologous stem cell transplantation indication haematology mainly multiple myeloma relapse lymphoma Hodgkin disease . Briefly , mobilization procedure , graft patient 's hematopoietic stem cell collect cytapheresis frozen . When patient reach complete remission conventional chemotherapy , benefit high dose myeloablative chemotherapy ( call `` conditioning regimen '' ) . The `` conditioning regimen '' target high antitumoral activity lead `` cytokine storm '' result `` program inflammation '' . 36 hour last condition regimen , CD34+ cell thaw infused patient . Thus neutropenia usually begin D4 post transplantation last 10 day , graft become `` functional '' . Thus , time duration neutropenia homogeneous . During neutropenia , fever sepsis frequent ( &gt; 80 % patient ) , thus , patient informative regard sepsis , easy possibility biological sampling '' program inflammation '' ( due condition regimen ) , inflammation sepsis , sepsis . Since patient hospitalize , kinetic monitoring quite easy</brief_summary>
	<brief_title>Sepsis Neutropenic Patients : Autologous Stem Cell Transplantation Model : Transcriptomic Approach</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<criteria>criterion require candidate ASCH service ( department ) ( age 18 66 year , myélome 1 ° reply partial line lymphoma complete answer one 2 ° line , absence preliminary visceral failure ) . Informed , willing patient give agreement write . Refusal patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>